AXL receptor tyrosine kinase as a therapeutic target in NSCLC
- Author(s): Bivona, Trever;
- Okimoto, RA;
- Bivona, TG
- et al.
Published Web Locationhttp://europepmc.org/articles/PMC5217513?pdf=render
© 2015 Okimoto and Bivona.The AXL receptor tyrosine kinase and its ligand, Gas6, regulate key processes in lung cancer growth, metastasis, and epithelial–mesenchymal transition-associated drug resistance. Gas6 and AXL expression have been correlated with p